Key Market Indicators
Ecuador's vaccination coverage for children aged one is projected to maintain its current level, remaining steady at 85% through to 2028. This figure reflects no change from the 85% coverage reported in 2023, indicating a stable trend since 1985. On the economic front, Ecuador's vaccine imports are anticipated to reach approximately $47.3 million by 2028, up from $45.4 million in 2023. This represents a modest compound annual growth rate (CAGR) of 0.5% year over year. Since 1996, the country's demand for vaccines has increased by an average of 1.8% annually. In terms of exports, Ecuador's vaccine shipments are expected to rise to around $585,000 by 2028, compared to $480,000 in 2023. This marks an average annual growth rate of 3%. Since 2008, the nation's vaccine supply has expanded at an average rate of 6.4% per year. In the global ranking for 2023, Ecuador placed 43rd, with the Philippines just ahead. Belgium, the United Kingdom, and France secured the second, third, and fourth spots, respectively.
